Actively Recruiting
Study of Brief Culturally Adapted Cognitive Behaviour Therapy for Adults with Obsessive-Compulsive Disorder in Pakistan
Led by Pakistan Association of Cognitive Therapists · Updated on 2025-11-18
166
Participants Needed
1
Research Sites
3 weeks
Total Duration
AI-Summary
What this Trial Is About
Obsessive-Compulsive Disorder OCD is characterized by unwanted intrusive thoughts called obsessions and repetitive actions called compulsions. This trial evaluates the effectiveness of Brief Culturally Adapted Cognitive Behaviour Therapy Ca-CBT specifically designed for OCD, focusing on adapting the therapy to the Pakistani cultural context. The study aims to provide evidence on how culturally tailored CBT can help manage OCD symptoms, addressing a gap in research for low and middle-income countries. Participants in the study are randomly assigned to one of two groups. One group receives the Ca-CBT manual alongside usual treatment, which typically includes medication and regular hospital visits. The therapy covers psychoeducation, symptom management, Exposure and Response Prevention ERP, relaxation techniques, mood and thought detection, cognitive restructuring, behavioral activation, problem solving, and communication skills. The other group receives only the usual treatment without the therapy manual or psychologist intervention. During the 6-week study, participants will undergo assessments measuring the therapys effectiveness and acceptability in reducing OCD symptoms. Secondary evaluations include changes in depression, anxiety, and daily functioning related to OCD. Researchers will monitor progress through thought diaries and symptom tracking. The total participation period and safety assessments extend up to study completion at the end of 2025.
CONDITIONS
Brief Title
Brief Culturally Adapted CBT for OCD
Research Team
M
Muhammad Aslam
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here